Overview
| Product name | Recombinant Human LILRA1/LIR-6/CD85i Protein |
|---|
| Catalog No. | RP01457 |
|---|
| Description | Recombinant Human LILRA1/LIR-6/CD85i Protein is produced by HEK293 cells expression system. The target protein is expressed with sequence (Pro17-Asn461) of human LILRA1/CD85i/LIR-6 (Accession #NP_006854.1) fused with a 6×His，Avi tag at the C-terminus. |
|---|
| Purity | > 90% by SDS-PAGE. |
|---|
| Endotoxin | < 1 EU/μg of the protein by LAL method. |
|---|
| Formulation | Lyophilized from a 0.22 μm filtered solution of PBS, pH 7.4, 5% trehalose, mannitol and 0.01% Tween80. |
|---|
| Species | Human |
|---|
| Calculated MW | 51.18 kDa |
|---|
Background
Leukocyte immunoglobulin-like receptors (LILRs) are inhibitory, stimulatory or soluble receptors encoded within the leukocyte receptor complex. Some LILRs are extensively polymorphic, and exhibit evidence for balancing selection and association with disease susceptibility. LILRA1 (LIR-6) can recognize MHC (major histocompatibility complex) class I or class I-like molecules, and high levels of sequence similarity among LILRA1, LILRA2 (ILT1), LILRA3 (ILT6) and LILRB1/B2.
Product information
| Synonym | LILRA1; CD85I; LIR-6; LIR6 |
|---|
| Expression Host | HEK293 cells |
|---|
| Tag | C-His&Avi |
|---|
| Swiss-Prot | |
|---|
| Gene ID | |
|---|
Usage guide
| Storage | Store at -20℃.Store the lyophilized protein at -20℃ to -80 ℃ up to 1 year from the date of receipt.
After reconstitution, the protein solution is stable at -20℃ for 3 months, at 2-8℃ for up to 1 week. |
|---|
| Reconstitution | Centrifuge the vial before opening. Reconstitute to a concentration of 0.1-0.5 mg/mL in sterile distilled water. Avoid vortex or vigorously pipetting the protein. For long term storage, it is recommended to add a carrier protein or stablizer (e.g. 0.1% BSA, 5% HSA, 10% FBS or 5% Trehalose), and aliquot the reconstituted protein solution to minimize free-thaw cycles. |
|---|
* For research use only. Not for therapeutic or diagnostic purposes.
